Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
This is a 16 subject trial to demonstrate the safety of allogeneic hMSCs administered via infusion therapy for diabetic subjects with endothelial dysfunction.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
In order to participate in this study, a subject Must Not:
Primary purpose
Allocation
Interventional model
Masking
16 participants in 4 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal